Listen "Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes - Module 1"
Episode Synopsis
Join melanoma authority Michael A. Davies, MD, PhD, University of Texas, MD Anderson Cancer Center, as he navigates the latest breakthroughs in immunotherapy and targeted treatments transforming outcomes for patients with melanoma. Discover how predictive biomarkers, strategic combination therapies, and personalized treatment sequencing are revolutionizing care across neoadjuvant, adjuvant, and metastatic settings. This podcast is essential listening for oncology professionals seeking evidence-based approaches to combat this challenging disease affecting over 100,000 Americans annually.
Click here to listen to module 2 of this podcast series: bit.ly/44yO9RB
Click here to claim your CME/NCPD credit: bit.ly/4iYmYD2
Click here to listen to module 2 of this podcast series: bit.ly/44yO9RB
Click here to claim your CME/NCPD credit: bit.ly/4iYmYD2
More episodes of the podcast Oncology Data Advisor
Optimizing CLL Care: Pharmacist-Led Strategies for Treatment Selection and Toxicity Management
02/10/2025
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care Module 2
11/08/2025
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1
11/08/2025
Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD + Activity Module 2
07/08/2025